| Literature DB >> 33740188 |
Pengfei Liu1,2,3, Shubin Chen1,4, Yaofeng Wang1,4,5,6, Xiaoming Chen1,4, Yiping Guo1, Chunhua Liu1,4, Haitao Wang1, Yifan Zhao1,4,7, Di Wu1,7, Yongli Shan1, Jian Zhang1, Chuman Wu1, Dongwei Li1, Yanmei Zhang1,4, Tiancheng Zhou1, Yaoyu Chen1,7, Xiaobo Liu1,7, Chenxu Li1,7, Lihui Wang8, Bei Jia9, Jie Liu10, Bo Feng5, Jinglei Cai11,12,13, Duanqing Pei14,15,16,17.
Abstract
A stable, rapid and effective neural differentiation method is essential for the clinical applications of human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) in treating neurological disorders and diseases. Herein, we established a novel and robust monolayer differentiation method to produce functional neural progenitor cells (NPCs) from human ESC/iPSCs on Type I Collagen. The derived cells not only displayed the requisite markers, but also behaved similarly to classic NPCs both in vitro and in vivo. Upon transplantation into traumatic brain injury model, the derived NPCs facilitated recovery from injury. We also found that SMAD signaling stayed down throughout the differentiation process on Type I Collagen, and the pluripotent signals were rapidly downregulated along with raising up of neural early markers on the third day. Meanwhile, ATAC-seq data showed the related mediation of distinct transcriptome and global chromatin dynamics during NPC induction. Totally, our results thus provide a convenient way to generate NPCs from human ESC/iPSCs for neural diseases' treatment.Entities:
Keywords: ESCs; NPCs; Type I Collagen; iPSCs; neural differentiation
Mesh:
Substances:
Year: 2021 PMID: 33740188 DOI: 10.1007/s11427-020-1897-0
Source DB: PubMed Journal: Sci China Life Sci ISSN: 1674-7305 Impact factor: 6.038